1st Swiss Translational Medicine Conference

to the patient -
by connecting people

Connecting the best minds in translational research

Collaborating on tomorrow’s discoveries

Supporting entrepreneurship in life science

Our Services

As the hub for translational research in the Swiss canton of Bern, we are teamed up with leading private companies, the University of Bern, the University Hospital of Bern (Inselspital), and a number of high-potential start-ups. Our facilities provide them, and you, with a unique space that thrives in an open innovation culture – what we call, the sitem+spirit.

Download Brochure

sitem-insel School is our partnership with the Medical Faculty of the University of Bern to deliver continuing education and research that connects the best minds in translational science


sitem-insel Enabling Facilities is our business, medical and research campus designed to encourage innovation and cooperation between all partners and stakeholders 


sitem-insel Promoting Services is our expert access to strategies and state-of-the-art modeling for evidence-based stories and value propositions that link ideas to commercial success 


Swiss Institute for Translational and Entrepreneurial Medicine

sitem-insel is a catalyst for a multidisciplinary collaborative approach to unlocking ‘bench to bedside’ innovation. We bring academia, government, industry, and science together in one place, with one goal: operational excellence in translational research. Cutting-edge research units, leading academics and consultants work together within our state-of-the-art 20,000 m2 facility based at the Insel-Campus Bern, Switzerland. Our mission is to establish, operate and develop a National Center of Excellence for Translational Medicine that professionalizes translation research for the benefit of patients, society and science. Clinic and industry, research and education: together, we are sitem-insel.


Innoforum is our networking event series which presents sitem-insel platforms and their innovations. Watch or join the webinars to exchange with platforms and stakeholders.

InnoForum #1

sitem-insel Promoting Services by Prof. Rudolf Blankart
HGF GmbH (Intellectual Property Specialists) by Mike Nelson

Innoforum #2

CSL Biologics Research Center by Adrian Zürcher, Alexander Schaub, Cédric Vonarburg, Marius Lötscher and Fabian Käsermann
Decomplix AG by Beni Hirt, CEO


Our achievements

Translational medicine offers a wealth of treatment opportunities. sitem-insel aims to enhance and improve the translatability of preclinical science into therapeutic advances. Our solution is to bring you – the stakeholders from academia, government, industry, and science – together in one place, with one goal: operational excellence in translational research.


Partners in the sitem-insel network


Investment in the long-term strategy


Occupancy in platforms facilities

In the University Hospital of the Insel Group and in the medical faculty, ideas and new findings are generated every day on how to improve people’s health, and quality of life. sitem-insel makes it possible to show how these findings can be put into practice for the benefit of patients. A great thing, that makes me proud as a Bernese, and as the President of the Insel Group. Keep up the good work!

Bernhard Pulver
President Insel Group AG

The Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel) is a research institution of national importance and international appeal. The project has been designated highest priority by the Swiss Confederation, which is why the Canton of Bern and the federal government will both be supporting the institution from 2017 to 2020 with approximately CHF 25 million each. Medical technology, pharmaceuticals and biotechnology are trendsetting branches, and sitem-insel strengthens the innovation potential of these branches, opening up new opportunities and providing the ideal working environment in the field of translational medicine.

Christoph Ammann
Minister of Economic Affairs and Member of the Government of the Canton of Bern

For someone who has worked for over 30 years in Pharma, Biotech, Medtech and a University Hospital like Inselspital, Translational Medicine has been a vision for many years. Much too long, we had to wait for an initiative like sitem-insel to quickly transform scientific solutions found by innovative researchers into clinical applications and products that have a real impact in our daily work and help to improve our patients lifes. That is why I personally have been committed to this project right from the start. The quality and speed with which sitem-insel was created is unique in Switzerland. The Insel Gruppe is very proud to be part of sitem-insel and we are looking forward to develop our common platforms successfully into the future.

Dr. med. h.c. Uwe E. Jocham
General Manager Insel Gruppe AG

sitem-insel is a truly unique public private partnership. It focuses on leading edge medical research and teaching with the aim to transform projects into scalable products. Kellerhals Carrard is an entrepreneurial law firm. We support our clients in their innovative projects and teach workshops. It follows that sitem and KC share joint values, which made it an easy decision to enter in a long-term collaboration agreement.

Dr. Beat Brechbuehl
Managing Partner, Kellerhals Carrard

Latest Updates

International Conference for Technology and Analysis of Seizures

The ICTALS conference (International Conference on Technology and Analysis of Seizures) gathers scientists and clinicians around one common goal: use quantitative methods to analyze seizures and better understand and treat the disorder.


 Translational Imaging Center

Title: Metabolic brain imaging at 7T MRI


HGF Gmbh

Title: The journey from laboratory to commercial product, licensing and IP considerations  

Medical Collection Inselspital Bern: Analogue Exhibits of the New Digital Museum

The medical collection comprises more than 10,000 exhibits, mainly from the period since 1900, representing activities, treatments, inventions, and objects from everyday hospital life. A small exhibition in our Atrium 3 currently provides insights into this diverse collection.

New EU Research Project “Screen4Care”: Accelerating Diagnosis for Rare Disease Patients Through Genetic Newborn Screening and Artificial Intelligence

An international public-private consortium of 35 partners, including sitem-insel and the University of Bern, announced the launch of Screen4Care – a research project that aims to significantly shorten the time required for rare disease diagnosis and efficient intervention.